Publications by authors named "Jacob Teitelbaum"
An Open-Label, Pilot Trial of HRG80™ Red Ginseng in Chronic Fatigue Syndrome, Fibromyalgia, and Post-Viral Fatigue.
Pharmaceuticals (Basel)
December 2021
Chronic fatigue syndrome and fibromyalgia (CFS/FMS) affect 2.1% of the world's population and ~10-25% of people who have had COVID-19. Previous clinical data suggested that a unique (C.
View Article and Find Full Text PDFA Hemp oil, CBD, and Marijuana Primer: Powerful Pain, Insomnia, and Anxiety-relieving Tools!
Altern Ther Health Med
June 2019
No Abstract Available.
View Article and Find Full Text PDFChronic fatigue syndrome, fibromyalgia, and myalgic encephalomyelitis: a clinical perspective.
Altern Ther Health Med
February 2014
The use of D-ribose in chronic fatigue syndrome and fibromyalgia: a pilot study.
J Altern Complement Med
November 2006
Objectives: Fibromyalgia (FMS) and chronic fatigue syndrome (CFS) are debilitating syndromes that are often associated with impaired cellular energy metabolism. As D-ribose has been shown to increase cellular energy synthesis in heart and skeletal muscle, this open-label uncontrolled pilot study was done to evaluate if D-ribose could improve symptoms in fibromyalgia and/or chronic fatigue syndrome patients.
Design: Forty-one (41) patients with a diagnosis of FMS and/or CFS were given D-ribose, a naturally occurring pentose carbohydrate, at a dose of 5 g t.